Contact Us

News and Events

Bora Pharmaceuticals Featured in Fierce Pharma – Bora’s Quest to Join Ranks of Top CDMOs

Bora Pharmaceuticals Featured in Fierce Pharma – Bora’s Quest to Join Ranks of Top CDMOs

Nov 10, 2022

Fierce Pharma features a discussion with CEO, Bobby Sheng in an article entitled "After Bora's biologics debut, CEO outlines quest to join ranks of top CDMOs". Published on November 10, 2022Thank you Fierce Pharma and author Fraiser Kansteiner Bora's focus on customer partnership is key to Bora's acquisition strategy. Bora's recent addition of biologics offerings with acquisition of Eden...

read more
Bora expands its CMDO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

Bora expands its CMDO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

Oct 3, 2022

Bora establishes a lead position in Taiwan's CDMO sector TAIWAN - Fast-growing contract development and manufacturing organization (CDMO), Bora Pharmaceuticals, has completed the acquisition of TWi Pharmaceutical Co.Ltd, a technology-based company specializing in development and commercialization of niche generic drugs. Acquiring TWi Pharmaceuticals adds two manufacturing facilities and will...

read more
Bora Pharmaceuticals acquires Eden Biologics CDMO Assets

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets

May 10, 2022

Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market Taiwan-based premier international contract development and manufacturing organization (CDMO) Bora Pharmaceuticals recently announced the establishment of Bora Biologics Co., Ltd., a CDMO platform for biologics. Besides Bora, investors into the new entity include Taishin...

read more
KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to manufacture generic product for filing in Japan

KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to manufacture generic product for filing in Japan

Aug 6, 2021

KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has contracted with Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals for the manufacturing of generic product for filing in Japan. KYOWA will be the first Japanese client for Bora’s Zhunan manufacturing site which is already USFDA, MHRA, and TFDA approved. This project will...

read more